Workflow
Publication of a transparency notification
Globenewswire· 2025-06-06 05:10
Publication of a transparency notification(in accordance with the Law of 2 May 2007 on disclosure of major holdings) On 4 June 2025, NV Bekaert SA crossed the threshold of 5%. Reason for the notification: passive crossing of a thresholdNotification by a parent undertaking or a controlling personPersons subject to the notification requirement: Stichting Administratiekantoor Bekaert, Chasséveld 1, 4811 DH Breda, NederlandNV Bekaert SA, Bekaertstraat 2, 8550 Zwevegem Date on which the threshold is crossed: 4 ...
Transparency Law
Globenewswire· 2025-06-06 05:05
Transparency LawDisclosure in accordance with the Law of 2 May 2007 Pursuant to Articles 15 §1 and 18 §1 of the Law of 2 May 2007 on the disclosure of major holdings in issuers whose shares are admitted to trading on a regulated market, NV Bekaert SA (“Bekaert”) publishes the following information: Status as of 4 June 2025 Basic data Total capital: € 159 782 000.00 Total number of securities conferring voting rights: 52 701 148 shares Total number of voting rights (the denominator): 52 701 148 (one voting r ...
TGS Commences Ultra-High Resolution 3D Seismic Survey for Green Volt Wind Development
Globenewswire· 2025-06-06 05:00
London, United Kingdom (06 June 2025) – TGS, a leading global provider of energy data and intelligence has commenced a geophysical survey for the pioneering Green Volt floating offshore wind farm. Mobilization initiated in Aberdeen last week and the work scheduled throughout June will include an ultra-high resolution 3D (UHR3D) seismic survey used to deliver detailed subsurface data for the floating wind farm’s site characterization. The Green Volt project is a joint venture between leading offshore wind d ...
Idorsia publishes invitations to bondholder meetings
Globenewswire· 2025-06-06 05:00
Ad hoc announcement pursuant to Art. 53 LR Bondholder meetings will take place on Wednesday, June 25, 2025, to vote on proposals to amend the terms of the two outstanding convertible bonds CB 2025 and CB 2028 Allschwil, Switzerland – June 6, 2025Idorsia Ltd (SIX: IDIA) today announced that following the expiry of the appeal period for the amended terms approved at the CB 2025 bondholder meeting of February 25, 2025 – during which no appeal was filed – it has published invitations to the next bondholder mee ...
Dassault Systèmes: Doubling EPS by 2029, 3D UNIV+RSES creating new growth opportunities
Globenewswire· 2025-06-06 05:00
Press ReleaseVELIZY-VILLACOUBLAY — June 6, 2025 Dassault Systèmes: Doubling EPS by 2029,3D UNIV+RSES creating new growth opportunities Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) hosts its 2025 Capital Markets Day at its headquarters in Vélizy-Villacoublay, France, today, June 6, 2025. The event, dedicated to financial analysts and investors, features a series of presentations by the Company’s executive management. It highlights how 3D UNIV+RSES mark a fundamental shift, providing the next gene ...
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
GlobeNewswire News Room· 2025-06-06 05:00
Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) in multiple preclinical models of chronic cough compared to reference drugs. Some of ...
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Multiple Chronic Cough Preclinical Models
Globenewswire· 2025-06-06 05:00
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today robust anti-tussive activity of its novel gamma-aminobutyric acid sub-type B receptor (GABAB) positive allosteric modulator (PAM) in multiple preclinical models of chronic cough compared to reference drugs. Some of ...
ChargePoint: Weak Quarter And Disappointing Outlook - Sell (Rating Downgrade)
Seeking Alpha· 2025-06-06 04:40
Group 1 - The focus has shifted towards offshore drilling, supply industry, and shipping, including tankers, containers, and dry bulk [1] - The fuel cell industry is being monitored as it is still in its early stages of development [1] Group 2 - The individual has extensive experience in auditing and trading, having navigated significant market events such as the dotcom bubble and the subprime crisis [2] - The research provided aims to maintain high quality despite language barriers [2]
Defiance Launches PLTZ: The First 2X Short ETF for Palantir Technologies Inc.
GlobeNewswire News Room· 2025-06-06 04:30
Core Viewpoint - Defiance ETFs has launched the Defiance Daily Target 2X Short PLTR ETF (Ticker: PLTZ), which is the first 2X short single-stock ETF aimed at providing amplified daily inverse exposure to Palantir Technologies Inc. [1][2] Group 1: Fund Objectives and Structure - PLTZ aims to achieve daily investment results that correspond to -2 times (-200%) the daily percentage change of Palantir's stock price, making it a tactical tool for active traders to express bearish views on Palantir's short-term movements [2][3] - The fund is designed for knowledgeable investors who actively monitor their portfolios, as it pursues a daily inverse leveraged investment objective [3][4] Group 2: Company Background - Palantir Technologies Inc. was founded in 2003 to support U.S. intelligence operations and now provides software solutions for complex data environments across both public and private sectors [1] - The company develops software platforms that integrate data and enhance decision-making for commercial enterprises and government agencies, including defense and intelligence sectors [12] Group 3: Investment Strategy and Risks - The fund utilizes swap contracts and options based on the share price of Palantir, exposing it to risks similar to owning shares of Palantir [8] - The use of derivatives, including swaps and options, introduces additional risks such as market volatility, counterparty risk, and potential lack of liquidity [14][16][17]
DocuSign Q1: Lowered Billing Growth Is Just Renewal Timing Issue
Seeking Alpha· 2025-06-06 04:00
Core Insights - The article does not provide specific insights or analysis regarding any companies or industries, focusing instead on disclaimers and disclosures related to the author's positions and affiliations [1][2]. Group 1 - No stock, option, or similar derivative positions are held by the author in any mentioned companies, nor are there plans to initiate such positions in the next 72 hours [1]. - The article expresses the author's personal opinions and is not compensated for the content, aside from Seeking Alpha [1]. - The views expressed may not reflect those of Seeking Alpha as a whole, and the analysts involved may not be licensed or certified [2].